Immunology of Infectious Disease News 4.33 August 24, 2016 | |
| |
TOP STORYAntibody-Mediated Protection against SHIV Challenge Includes Systemic Clearance of Distal Virus Scientists administered a fully protective dose of the broadly neutralizing antibody PGT121 to rhesus monkeys and challenged them intravaginally with simian-human immunodeficiency virus (SHIV)-SF162P3. In PGT121-treated animals, they detected low levels of viral RNA and viral DNA in distal tissues for several days following challenge. [Science] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists sought to determine the specific mechanisms regulating neutrophil pyroptosis in Pseudomonas aeruginosa strain PAO1 lung infection and to identify the pathological role of this process. [Mucosal Immunol] Abstract Lung-resident T cells had reduced KLRG1 and increased CXCR3 expression, an intermediate state of Th1 differentiation that has been associated with M. tuberculosis protection. Importantly, KLGR1− CXCR3+ cells were also enriched in the lung vasculature and peripheral circulation of vaccinated animals, but not controls. [Mucosal Immunol] Full Article NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection Investigators performed a longitudinal analysis of the human NK cell response to tick-borne encephalitis virus infection in a cohort of infected individuals from the onset of severe clinical symptoms to the convalescence phase. NK cell activation, as measured by expression of Ki67, was apparent at the time of hospitalization. [J Immunol] Abstract Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection Researchers compared profiles of bronchoalveolar lavage (BAL) cells of humans and cynomolgus macaques before and after Mycobacterium tuberculosis (Mtb) infection. A simple gating strategy effectively defined BAL T-cell and phagocyte populations in both species. BAL from Mtb-naive humans and macaques showed similar differential cell counts. [Am J Respir Cell Mol Biol] Abstract HIVHuman Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection The preferential loss of T helper 17 (Th17) cells has been attributed to high CD4, CCR5, and CXCR4 expression. Investigators showed that Th17 cells also exhibit heightened permissiveness to productive HIV infection. [J Virol] Abstract The authors demonstrated that VC-chimeric antigen receptor (CAR)-T cells induced T cell-mediated cytolysis of cells expressing HIV-1 Env proteins and significantly inhibited HIV-1 rebound after removal of antiviral inhibitors in a viral infectivity model in cell culture which mimics the termination of the combined antiretroviral therapy (cART) in clinic. [J Virol] Abstract Researchers investigated HIV transmission from monocyte-derived dendritic cells vs monocytes to helper T cell (Th)17 and Th1 cells using an allogeneic coculture model. [J Leukoc Biol] Abstract Immune Activation by Mycobacterium tuberculosis in HIV-Infected and -Uninfected Subjects The authors investigated the influence of M. tuberculosis infection on immune-activation biomarkers, both in HIV-infected and -uninfected subjects. [J Acquir Immune Defic Syndr] Abstract Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSMemory γδ T Cells–Newly Appreciated Protagonists in Infection and Immunity The authors discuss recent reports of memory-type responses attributed to γδ T cells and assess this underappreciated facet of these enigmatic cells. [Trends Immunol] Abstract Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
INDUSTRY NEWSViiV Healthcare announced the start of a Phase III program to support regulatory filings for a two-drug regimen of dolutegravir and lamivudine as a treatment for HIV-1 infection in adults who have not received prior antiretroviral therapy. [ViiV Healthcare] Press Release Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research The IHV at the University of Maryland School of Medicine announced a $14.4 million grant from the U.S. National Institute of Allergy and Infectious Diseases to tackle a significant scientific global challenge in HIV vaccine research – the inability to produce long-lasting antibodies to protect against HIV infection. [Institute of Human Virology] Press Release Xenetic Biosciences, Inc. announced that it has commenced a collaboration with Excivion Ltd. to develop a vaccine against Zika and dengue viruses. [Xenetic Biosciences, Inc.] Press Release Regeneron Pharmaceuticals, Inc. announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services to manufacture and study two antibody therapies for the potential prevention and treatment of Middle East Respiratory Syndrome (MERS). [Regeneron Pharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSA Tale of Two Governments: The Politician Behind Argentina’s Science Growth Lino Barañao, the only minister to stay in power after last year’s elections, lays out his plans. [Nature News] Editorial Spiking Genomic Databases with Misinformation Could Protect Patient Privacy Large genomic databases are indispensable for scientists looking for genetic variations associated with diseases. But they come with privacy risks for people who contribute their DNA. A 2013 study showed that hackers could use publicly available information on the Internet to identify people from their anonymized genomic data. [Nature News] Editorial UK Government Gives Brexit Science Funding Guarantee British scientists say they’re relieved by a government promise to guarantee them funding for existing EU research projects, even after the country leaves the European Union. But the reassurance only partly allays concerns about Brexit’s effect on UK science. [Nature News] Editorial Candidate Cancer Drug Suspected after Death of Three Patients at an Alternative Medicine Clinic A new type of cancer drug developed at Johns Hopkins University in Baltimore, Maryland, but not yet tested in clinical trials may have triggered the deaths of three patients who were undergoing an alternative cancer treatment by a nonmedical practitioner in Germany. Germany has many such practitioners, and the field is loosely regulated. The public prosecutor in Germany is now investigating whether the case constitutes involuntary manslaughter. [ScienceInsider] Editorial Obama’s Science Legacy: Uneven Progress on Scientific Integrity Many researchers who watched Barack Obama’s inauguration in 2009 were thrilled by his pledge to “restore science to its rightful place”. But scientists and legal scholars say that, in many ways, Obama has failed to live up to that lofty promise. [Nature News] Editorial
| |
EVENTSNEW 5th Australian College for Infection Prevention and Control (ACIPC) 2016 Conference Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Researcher – Translational Immunology (University of Eastern Finland) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) Senior Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.) Clinical Lecturer – Pediatric Emergency Medicine with Infectious Diseases (University of Bristol) Postdoctoral Fellow(s) – Biomedical Diagnostics and Global Health Technologies (Cornell University) Faculty Position – Immunology (Vanderbilt University Medical Center) Postdoctoral Fellow – Mucosal Immunology (University of Utah) Research Chair – Immunology and Infectious Disease (University of Edinburgh) Scientist – Infectious Disease (Infectious Disease Research Institute) PhD Positions – Infection Biology and Immunology (ZIBI Graduate School) Senior Researcher – Epidemiology of Infectious Diseases (El Colegio de la Frontera Sur) Postdoctoral Fellow – Infectious Disease (Metabiota) Postdoctoral Fellow – Malaria Genetics (Wellcome Trust Sanger Institute) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|